No. MVP038/2020 May 15, 2020 Subject: Management Discussion and Analysis for the three - month period ended 31 March 2020 To: President and Manager The Stock Exchange of Thailand M Vision Public
ที่ FPI Ref. FPI.007/2020 15 July 2020 Subject : Management Discussion & Analysis of Performance Results of Quarter 1 2020 To : Board of Directors and President of The Stock Exchange of Thailand
period of 2019 To : The President of the Stock Exchange of Thailand The Company would like to provide details of changes in Profit and Loss as shown in the six-month period ending 30 June 2020 reviewed
Page 1 of 4 No. RJH – SET 9/2020 10 August 2020 Subject : Management’s Discussion and Analysis for the Second Quarter of 2020 To : The President The Stock Exchange of Thailand Rajthanee Hospital
ที่ FPI Ref. FPI.008/2020 11 August 2020 Subject : Management Discussion & Analysis of Performance Results of Quarter 2 2020 To : Board of Directors and President of The Stock Exchange of Thailand
[COMPANY NAME] Ref.: EFORL IR037/2020 September 11, 2020 Subject: Management Discussion and Analysis Quarter 2 Ending 30 June 2020 To President The Stock Exchange of Thailand 1. Overview financial
Page 1 of 4 No. RJH – SET 7/2020 11 May 2020 Subject : Management’s Discussion and Analysis for the First Quarter of 2020 To : The President The Stock Exchange of Thailand Rajthanee Hospital Public
ที่ บช NO. AC. 02/2020 14 May 2020 Subject: Clarification of changes in operating performance of more than 20% To: The President of the Stock Exchange of Thailand M.K. Real Estate Development Plc
August 11, 2020 Subject: Management’s Discussion and Analysis for the second Quarter of 2020 To: The President The Stock Exchange of Thailand (SET) DOD Biotech Public Company Limited and its subsidiaries
executive of any listed company on the Stock Exchange and are banned from holding such positions while the complaint procedure is underway. In any case, filing a criminal complaint commences the criminal